What was the grant value per share for Dr. Turner’s Kronos Worldwide (KRO) stock award?

The stock award to Dr. R. Gerald Turner used a grant value of $7.22 per share for 5,550 shares. This price reflects the valuation for reporting purposes of the common stock issued under the 2012 Director Stock Plan.

Kronos Worldwide director granted 5,550 shares

Kronos Worldwide director Dr. R. Gerald Turner received a stock award.

Accepted by SEC EDGAR 05/14/2026 - 01:47 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Kronos Worldwide director Dr. R. Gerald Turner received a stock award. On May 13, 2026, he acquired 5,550 shares of Kronos Worldwide common stock at a grant value of $7.22 per share.

The shares were issued for no cash consideration under the Kronos Worldwide, Inc. 2012 Director Stock Plan as part of his board compensation. Following this grant, Dr. Turner directly holds 37,595.618 shares of the company’s common stock.

Insider Trade Summary

Grant/Award: 5,550 shares

Grant/Award 1 txn

Insider TURNER R GERALD DR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock $0.01 par value per share	5,550	$7.22	$40K

Holdings After Transaction: Common Stock $0.01 par value per share — 37,595.618 shares (Direct)

Footnotes (1)

F1. Shares issued for no cash consideration to directors under the Kronos Worldwide, Inc. 2012 Director Stock Plan.

Key Figures

Shares granted: 5,550 shares Grant value per share: $7.22 per share Shares held after transaction: 37,595.618 shares +1 more

4 metrics

Shares granted 5,550 shares Director stock award on May 13, 2026

Grant value per share $7.22 per share Valuation used for the stock grant

Shares held after transaction 37,595.618 shares Director’s direct holdings after grant

Transaction code A (Grant, award, or other acquisition) SEC Form 4 classification of the transaction

Key Terms

Form 4, Grant, award, or other acquisition, 2012 Director Stock Plan, Common Stock $0.01 par value per share

4 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

2012 Director Stock Plan financial

"under the Kronos Worldwide, Inc. 2012 Director Stock Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Kronos Worldwide (KRO) report for Dr. R. Gerald Turner?

Kronos Worldwide reported that director Dr. R. Gerald Turner received a grant of 5,550 shares of common stock. The award was made under the 2012 Director Stock Plan and represents stock-based compensation rather than an open-market purchase.

How many Kronos Worldwide (KRO) shares does Dr. R. Gerald Turner hold after this grant?

After the May 13, 2026 stock grant, Dr. R. Gerald Turner directly holds 37,595.618 shares of Kronos Worldwide common stock. This total includes the newly awarded 5,550 shares issued under the company’s 2012 Director Stock Plan.

Was cash paid for the Kronos Worldwide (KRO) shares granted to Dr. Turner?

No cash was paid for these shares. The filing states that 5,550 shares were issued to Dr. R. Gerald Turner for no cash consideration under the Kronos Worldwide, Inc. 2012 Director Stock Plan as part of his director compensation.

Is Dr. Turner’s Kronos Worldwide (KRO) Form 4 transaction a market purchase or a compensation grant?

The Form 4 shows a compensation grant, not a market purchase. Transaction code “A” and the footnote explain that 5,550 shares were issued for no cash consideration under the 2012 Director Stock Plan to compensate Dr. R. Gerald Turner as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TURNER R GERALD DR

(Last)

(First)

(Middle)

5430 LBJ FREEWAY, SUITE 1700

(Street)

DALLAS

TEXAS

75240

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KRONOS WORLDWIDE INC [ KRO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock $0.01 par value per share	05/13/2026		A⁽¹⁾		5,550	A	$7.22⁽¹⁾	37,595.618	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares issued for no cash consideration to directors under the Kronos Worldwide, Inc. 2012 Director Stock Plan.

	Jane R. Grimm, Attorney-in-fact, for Dr. R. Gerald Turner	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR